Angiotensin Converting Enzyme Inhibitor [EPC]

126553 reported adverse events

Drugs of this class: RAMIPRIL CAPTOPRIL TRANDOLAPRIL CAPTOPRIL AND HYDROCHLOROTHIAZIDE TRANDOLAPRIL AND VERAPAMIL HYDROCHLORIDE TRANDOLAPRIL TABLETS

These side effects are most commonly reported by patients taking drugs of the Angiotensin Converting Enzyme Inhibitor [EPC] class:

# Side effect Count
0 DYSPNOEA 8081
1 FATIGUE 7228
2 NAUSEA 6974
3 DIARRHOEA 6481
4 DIZZINESS 6329
5 DRUG INEFFECTIVE 6018
6 VOMITING 5237
7 PAIN 4926
8 FALL 4885
9 ACUTE KIDNEY INJURY 4847
See all common reactions for Angiotensin Converting Enzyme Inhibitor [EPC]

Drugs of the Angiotensin Converting Enzyme Inhibitor [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 DEEP VEIN THROMBOSIS POSTOPERATIVE 232 0.3816
1 SWOLLEN JOINT COUNT INCREASED 367 0.2878
2 RHEUMATIC FEVER 423 0.2493
3 FACET JOINT SYNDROME 244 0.2339
4 PRODUCT MONITORING ERROR 231 0.1729
5 DUODENAL ULCER PERFORATION 625 0.1601
6 RHEUMATOID FACTOR POSITIVE 520 0.1401
7 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 563 0.1345
8 PEMPHIGUS 1111 0.1323
9 PERIPHERAL VENOUS DISEASE 259 0.1275
See all enriched reactions for Angiotensin Converting Enzyme Inhibitor [EPC]